{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:08:50Z","timestamp":1762643330979,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002076","name":"Emergency Medicine Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.rcsop.2021.100062","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T15:34:13Z","timestamp":1629214453000},"page":"100062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pilot survey of prescription opioid use patterns and engagement with harm-reduction strategies in emergency department patients"],"prefix":"10.1016","volume":"3","author":[{"given":"Lindsay M.","family":"Fox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri","family":"Shastry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avis","family":"Harper-Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Ramdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex F.","family":"Manini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"CDC","key":"10.1016\/j.rcsop.2021.100062_bb0005"},{"issue":"43","key":"10.1016\/j.rcsop.2021.100062_bb0010","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"26","key":"10.1016\/j.rcsop.2021.100062_bb0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u20132015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"year":"2020","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55)","author":"Abuse","key":"10.1016\/j.rcsop.2021.100062_bb0020"},{"year":"2013","series-title":"Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits","author":"Abuse","key":"10.1016\/j.rcsop.2021.100062_bb0025"},{"issue":"9","key":"10.1016\/j.rcsop.2021.100062_bb0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.15585\/mmwr.mm6709e1","article-title":"Vital Signs\u00a0: trends in emergency department visits for suspected opioid overdoses \u2014 United States, July 2016\u2013September 2017","volume":"67","author":"Vivolo-Kantor","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.rcsop.2021.100062_bb0035","first-page":"1","article-title":"Mortality in the United States, 2016","volume":"293","author":"Kochanek","year":"2017","journal-title":"NCHS Data Brief"},{"year":"2019","series-title":"CDC\/NCHS, National Vital Statistics System, Mortality","key":"10.1016\/j.rcsop.2021.100062_bb0040"},{"author":"Wide-Ranging Online Data for Epidemiologic Research (WONDER)","key":"10.1016\/j.rcsop.2021.100062_bb0045"},{"issue":"4","key":"10.1016\/j.rcsop.2021.100062_bb0050","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s11606-012-2225-z","article-title":"Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008-2009","volume":"28","author":"Johnson","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"13","key":"10.1016\/j.rcsop.2021.100062_bb0055","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA."},{"issue":"7","key":"10.1016\/j.rcsop.2021.100062_bb0060","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","article-title":"Opioid dose and drug-related mortality in patients with nonmalignant pain","volume":"171","author":"Gomes","year":"2011","journal-title":"Arch Intern Med"},{"issue":"15","key":"10.1016\/j.rcsop.2021.100062_bb0065","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain-- United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA."},{"author":"Centers for Medicare and Medicaid Services (CMS)","key":"10.1016\/j.rcsop.2021.100062_bb0070"},{"issue":"7","key":"10.1016\/j.rcsop.2021.100062_bb0075","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/14740338.2016.1177509","article-title":"Safety concerns with long-term opioid use","volume":"15","author":"Harned","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"10.1016\/j.rcsop.2021.100062_bb0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain."},{"issue":"10","key":"10.1016\/j.rcsop.2021.100062_bb0085","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4088\/JCP.15m09963","article-title":"Psychiatric disorders among patients seeking treatment for co-occurring chronic pain and opioid use disorder","volume":"77","author":"Barry","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rcsop.2021.100062_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.genhosppsych.2019.04.008","article-title":"IATROGENIC opioid use disorder, chronic pain and psychiatric comorbidity: A systematic review","volume":"59","author":"van Rijswijk","year":"2019","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"10.1016\/j.rcsop.2021.100062_bb0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/HRP.0000000000000052","article-title":"Long-term course of opioid addiction","volume":"23","author":"Hser","year":"2015","journal-title":"Harv Rev Psychiatry"},{"issue":"6","key":"10.1016\/j.rcsop.2021.100062_bb0100","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/j.pain.0000000000000892","article-title":"Polysubstance use and misuse or abuse of prescription opioid analgesics: a multi-level analysis of international data","volume":"158","author":"Morley","year":"2017","journal-title":"Pain."},{"issue":"4","key":"10.1016\/j.rcsop.2021.100062_bb0105","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1037\/adb0000090","article-title":"Predictors of patient retention in methadone maintenance treatment","volume":"29","author":"Proctor","year":"2015","journal-title":"Psychol Addict Behav"},{"issue":"3","key":"10.1016\/j.rcsop.2021.100062_bb0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.pain.2010.08.002","article-title":"Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain","volume":"151","author":"Morasco","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.rcsop.2021.100062_bb0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2006.02.005","article-title":"When is a little knowledge dangerous? Circumstances of recent heroin overdose and links to knowledge of overdose risk factors","volume":"84","author":"Dietze","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.rcsop.2021.100062_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.addbeh.2018.05.022","article-title":"Screening emergency department patients for opioid drug use: a qualitative systematic review","volume":"85","author":"Sahota","year":"2018","journal-title":"Addict Behav"},{"key":"10.1016\/j.rcsop.2021.100062_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/add.14991","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services","author":"Krawczyk","year":"2020","journal-title":"Addiction."},{"issue":"4","key":"10.1016\/j.rcsop.2021.100062_bb0130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1370\/afm.2098","article-title":"Mortality associated with time in and out of buprenorphine treatment in french office-based general practice: a 7-year cohort study","volume":"15","author":"Dupouy","year":"2017","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.rcsop.2021.100062_bb0135","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ."},{"issue":"5","key":"10.1016\/j.rcsop.2021.100062_bb0140","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009","volume":"103","author":"Schwartz","year":"2013","journal-title":"Am J Public Health"},{"issue":"16","key":"10.1016\/j.rcsop.2021.100062_bb0145","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA."},{"issue":"6","key":"10.1016\/j.rcsop.2021.100062_bb0150","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","article-title":"Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention","volume":"32","author":"D\u2019Onofrio","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1016\/j.rcsop.2021.100062_bb0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11920-017-0783-9","article-title":"Update on barriers to pharmacotherapy for opioid use disorders","volume":"19","author":"Sharma","year":"2017","journal-title":"Curr Psychiatry Rep"},{"issue":"8","key":"10.1016\/j.rcsop.2021.100062_bb0160","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.rcsop.2021.100062_bb0165","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.annemergmed.2016.07.027","article-title":"Factors associated with participation in an emergency department\u2013based take-home naloxone program for at-risk opioid users","volume":"69","author":"Kestler","year":"2017","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.rcsop.2021.100062_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2018.03.055","article-title":"Rate of patients at elevated risk of opioid overdose visiting the emergency department","author":"Pedigo","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"RR-1","key":"10.1016\/j.rcsop.2021.100062_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain \u2014 United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.rcsop.2021.100062_bb0180","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugpo.2018.07.003","article-title":"Awareness and access to naloxone necessary but not sufficient: examining gaps in the naloxone cascade","volume":"59","author":"Tobin","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"34","key":"10.1016\/j.rcsop.2021.100062_bb0185","doi-asserted-by":"crossref","first-page":"945","DOI":"10.15585\/mmwr.mm6734a2","article-title":"Opportunities to prevent overdose deaths involving prescription and illicit opioids, 11 states, July 2016\u2013June 2017","volume":"67","author":"Mattson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276621000627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276621000627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:04:39Z","timestamp":1762643079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276621000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":37,"alternative-id":["S2667276621000627"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2021.100062","relation":{},"ISSN":["2667-2766"],"issn-type":[{"type":"print","value":"2667-2766"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot survey of prescription opioid use patterns and engagement with harm-reduction strategies in emergency department patients","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2021.100062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100062"}}